<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-12-15 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-12-15/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-12-15"><meta property="og:description" content="ğŸ“… Daily Report - 2025-12-15 ä»Šæ—¥ç­›é€‰å‡º 21 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-12-15T00:00:00+00:00"><meta property="article:modified_time" content="2025-12-15T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week502025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-12-15"><meta itemprop=description content="ğŸ“… Daily Report - 2025-12-15 ä»Šæ—¥ç­›é€‰å‡º 21 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-12-15T00:00:00+00:00"><meta itemprop=dateModified content="2025-12-15T00:00:00+00:00"><meta itemprop=wordCount content="1909"><meta itemprop=keywords content="Research,Daily,Week502025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-12-15"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-12-15 ä»Šæ—¥ç­›é€‰å‡º 21 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-15</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-12-15T00:00:00Z>2025-12-15</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-12-15>ğŸ“… Daily Report - 2025-12-15</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>21</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>1</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
NELFè›‹ç™½åœ¨ç™Œç—‡ç»†èƒä¸­ï¼Œé€šè¿‡é˜»æ­¢è½¬å½•è¯»è¿‡åˆ°DNAå¤åˆ¶åŒºï¼Œé˜²æ­¢åŸºå› ç»„ä¸ç¨³å®šï¼Œæ˜¯ç»´æŒç™Œç—‡ç»†èƒç¨³æ€çš„å…³é”®æœºåˆ¶ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚ºç»„ç»‡åŠŸèƒ½åŒºéš”ç ”ç©¶ï¼ˆOPæ‚£è€…ï¼‰</li><li>è‚è„å…ç–«ç»†èƒå“åº”è‚ç‚æ¨¡å‹</li><li>è‚ é“èŒç¾¤å¯¹éœä¹±ç”Ÿç‰©è†œå½¢æˆçš„å½±å“</li><li>éé˜»å¡æ€§æ— ç²¾å­ç—‡ä¸­lncRNAåœ¨ç²¾åŸç»†èƒå‘è‚²ä¸­çš„è°ƒæ§</li><li>ç™½è¡€ç—…ä¸­PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿çš„åŠŸèƒ½ä¸æœºåˆ¶</li><li>è§†ç½‘è†œå¢æ®–æ€§ç—…å˜ä¸­æˆçº¤ç»´ç»†èƒå¼‚è´¨æ€§</li><li>å“®å–˜æ‚£è€…ç”Ÿç‰©åˆ¶å‰‚æ²»ç–—çš„è½¬å½•ç»„å­¦å·®å¼‚</li><li>ç™Œç»†èƒé€šè¿‡å¾®å°RNAè½¬ç§»ä¾µè¢­æ€§</li><li>ç»“è‚ ç™Œç»†èƒå¯¹CTX-439çš„ååº”</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºç»„ç»‡åŠŸèƒ½éš”å®¤ã€‚</li><li>å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼ˆChIP-Seq, RNA-seq, ATAC-seq, TT-seq, POINT-seq, FLAM-Seq, RIP-Seqï¼‰è”åˆç ”ç©¶NELFåŠŸèƒ½ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (21æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE250385 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºOPæ‚£è€…è‚ºç»„ç»‡çš„åŠŸèƒ½åŒºå®¤åŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ying Tang ; Cuilin Chu ; Siyuan Bu ; Qin Sun ; Airan Liu ; Lingyan Huang ; Hongmei WangSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensTo characterize the spatial characteristics of the lung tissue of OP patient, we collected lung samples for Visium CytAssist from one patient with OP</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250385">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>GSE288402 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ChIP-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nakayama Chihiro ; Daigaku Yasukazu ; Aoi Yuki ; Fang Qi ; Kimura Hiroshi ; Shilatifard Ali ; Tellier Michael ; Nojima TakayukiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288402">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>GSE253012 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chihiro Nakayama ; Yasukazu Daigaku ; Yuki Aoi ; Qi Fang ; Hiroshi Kimura ; Ali Shilatifard ; Michael Tellier ; Takayuki NojimaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253012">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>GSE253011 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chihiro Nakayama ; Yasukazu Daigaku ; Yuki Aoi ; Qi Fang ; Hiroshi Kimura ; Ali Shilatifard ; Michael Tellier ; Takayuki NojimaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253011">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>GSE313240 æ˜¯æ¥è‡ª Alb-WT Bicd2fl/fl å’Œ Alb-Cre Bicd2fl/fl å°é¼ ï¼ˆç» S-100 è¯±å¯¼çš„è‡ªèº«å…ç–«æ€§è‚ç‚æ¨¡å‹ï¼‰è‚è„å…ç–«ç»†èƒçš„å•ç»†èƒ RNA æµ‹åºæ•°æ®ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wenyu Tian ; Weixuan Wang ; Dan LvSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo determine the changes in liver immune cells upon hepatic Bicd2 deficiency, we performed scRNA-seq to analyze the hepatic immune microenvironment in Alb-WT Bicd2fl/fl and Alb-Cre Bicd2fl/fl mice subjected to S-100 induced AIH model.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313240">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE313194 æŸ æª¬é…¸è‚ è¡£èŒåŠå…¶ç›¸å…³è‚ é“å¾®ç”Ÿç‰©ç¾¤ç‰©ç§é€šè¿‡äº§ç”Ÿç”Ÿç‰©æ´»æ€§å°åˆ†å­æ¥è°ƒèŠ‚éœä¹±å¼§èŒç”Ÿç‰©è†œçš„å½¢æˆ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Antunes L CaetanoSeries Type : Expression profiling by high throughput sequencingOrganism : Vibrio cholerae C6706Cholera is a deadly diarrheal disease that affects millions of people globally. Although V. cholerae, the causative agent of the disease, has been extensively studied in isolation, it was relatively recently that scientists started investigating its interactions with the gut microbiota. Our group and others previously showed that microbiota-derived metabolites significantly influence V. cholerae behavior. By investigating how an organic extract of human feces affects V. cholerae gene expression, we recently showed that gut metabolites strongly suppress swimming motility, a virulence factor important for host colonization. Interestingly, extracts of pure cultures of a single gut commensal, Enterocloster citroniae, recapitulated this inhibitory effect. Here, we present a comprehensive examination of the effect of small molecules produced by E. citroniae and related species on V. cholerae behavior. We show that E. citroniae small molecules inhibit motility by various V. cholerae strains. We also show that several phylogenetically related species produce this activity, although the magnitude of the effect varies between strains. Using biofilm formation assays in static and shear flow conditions, we show that V. cholerae strongly induces biofilm formation in response to E. citroniae metabolites. Transcriptome and reporter analyses show that several genes involved in the synthesis of an extracellular polysaccharide are induced by growth in the presence of E. citroniae metabolites. Lastly, we show that V. cholerae interactions with host epithelial cells are also modulated by compounds produced by this commensal. These findings advance our understanding of microbiome-pathogen interactions and how commensal bacteria influence V. cholerae virulence through the production of small molecules. In the future, this knowledge may be used to design novel microbiome-based therapeutic approaches to combat cholera and other infections.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313194">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE313132 ç‚ç—‡è¯±å¯¼çš„lncRNA SNHG1é€šè¿‡IL-17Aä¿¡å·é€šè·¯è°ƒæ§éæ¢—é˜»æ€§æ— ç²¾å­ç—‡ä¸­çš„ç²¾åŸç»†èƒå‘è‚²</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yongtong Zhu ; Maocai Li ; Xiaomin Zhan ; Li Liu ; Cairong Chen ; Yao Zhou ; Pei He ; Rui HuaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusNon-obstructive azoospermia (NOA) is a critical subtype of male infertility associated with inflammation. However, the molecular mechanisms underlying this phenomenon remain poorly understood. This study investigated the role of the inflammation-activated long non-coding RNA SNHG1 in NOA pathogenesis. Using lipopolysaccharide (LPS)-induced orchitis mouse models and spermatogonium cell lines (GC-1 spg and TCAM-2), we observed that both SNHG1 and the transcription factor SP1 were significantly upregulated, correlating with spermatogonium proliferation and loss of stemness. Mechanistically, SP1 directly binds to and transcriptionally activates the SNHG1 promoter, whereas SNHG1 knockdown rescued LPS-induced spermatogonium dysfunction without affecting SP1 expression. RNA-seq revealed that SNHG1 overexpression activated the IL-17A signaling pathway. Notably, IL-17A receptor blockade (Brodalumab) reversed the SNHG1-mediated proliferation arrest and stemness. Our findings demonstrated that the SP1-SNHG1-IL-17A axis drives inflammatory spermatogenic failure, suggesting that IL-17A inhibition is a potential therapeutic strategy for NOA.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313132">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE255449 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Siyao Guo ; Shuibin LinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe polyadenylation of mRNA is pivotal for mRNA stability and efficient mRNA translation. The length of poly(A) tail is dynamically changed under various physiological conditions; however, the functions and mechanisms of aberrant poly(A) length control in cancers remain poorly understood. Here we uncovered the aberrant lengthening of poly(A) tail and particularly upregulated expression of poly(A) polymerase alpha (PAPOLA) in acute myeloid leukemia (AML), and the elevated PAPOLA expression significantly correlated with unfavorable AML outcomes. We further demonstrated the critical oncogenic functions of PAPOLA-mediated poly(A) lengthening in promoting AML leukemogenesis and leukemia stem cell self-renewal using human primary AML samples, AML cells and various mouse leukemogenesis models. Mechanistically, we identified GSTM2 as a key downstream target of PAPOLA that regulated metabolic reprogramming through the HNE-DLD axis to promote AML initiation and progression. Moreover, PAPOLA inhibitor cordycepin effectively blocked metabolic reprogramming and AML leukemogenesis in vivo. Overall, our study uncovers the novel functional link between aberrant poly(A) lengthening and cellular metabolic reprogramming in AML, and provides a molecular basis for development of an effective therapeutic strategy for AML patients.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255449">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE294329 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºå¢ç”Ÿæ€§ç»ç’ƒä½“è§†ç½‘è†œç—…å˜è†œä¸­æˆçº¤ç»´ç»†èƒçš„å¼‚è´¨æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fengjuan Gao ; Yuqiao Ju ; Lili Zhang ; Ting Zhang ; Qing Chang ; Shunxiang Gao ; Xin Huang ; Yuan Zong ; Gezhi XuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensProliferative vitreoretinopathy (PVR) is a vision-threatening fibrotic disorder characterized by pathological membrane formation, yet its cellular and molecular mechanisms remain incompletely understood. Here, we employed single-cell RNA sequencing (scRNA-seq) to profile 18,213 cells from 5 human PVR membranes (PVRMs), uncovering cellular heterogeneity and novel pathogenic pathways.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294329">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE287936 DNAç”²åŸºåŒ–å’ŒlncRNAè¡¨è¾¾æ§åˆ¶å°è®°åŸºå› åŒºåŸŸçš„å¼‚æ­¥DNAå¤åˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmethylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yui Imaizumi ; Robert Feil ; Jean-Charles CadoretSeries Type : Genome variation profiling by genome tiling arrayOrganism : Mus musculusEukaryotic genomes are structured in zones that replicate predominantly early or late. Besides these genome-wide patterns of replication timing (RT), some genes display asynchronous replication between the two alleles in certain stem cells, brought about by stochastic processes and genetic polymorphisms. To what extent epigenetic modifications control asynchronous replication remains unclear. As a paradigm to address this question we explored imprinted chromosomal domains, at which parental DNA methylation imprints mediate parental allele-specific gene expression. Our genome-wide and locus-specific RT assays in mono-parental and hybrid mouse embryonic stem cells (mESCs) reveal a pronounced replication asynchrony between the parental chromosomes at the Dlk1-Dio3 and Snrpn domains. This asynchrony is strictly parent-of-origin dependent. By generating a range of mutant mESC lines, we find that the replication asynchrony at Dlk1-Dio3 is mediated by parental allele-specific methylation at DMRs (Differentially Methylated Regions). Moreover, lncRNA polycistron expression controls early replication across parts of the domain on the maternal chromosome. As a result, at these imprinted domains, RT domains become unlinked from 3D chromatin architecture as assayed by Hi-C. Our combined data highlight how parental DNA methylation imprints and lncRNA expression can locally be used to override intrinsic RT domain organization.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287936">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 11 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>7</td></tr><tr><td>leukemia</td><td>5</td></tr><tr><td>RNA-seq</td><td>3</td></tr><tr><td>transcriptomics</td><td>2</td></tr><tr><td>sequencing</td><td>1</td></tr><tr><td>ChIP-seq</td><td>1</td></tr><tr><td>methylation</td><td>1</td></tr><tr><td>ATAC-seq</td><td>1</td></tr><tr><td>carcinoma</td><td>1</td></tr><tr><td>immune</td><td>1</td></tr><tr><td>scRNA</td><td>1</td></tr><tr><td>gut</td><td>1</td></tr><tr><td>regex:gut(-?microbiome)?</td><td>1</td></tr><tr><td>inflammation</td><td>1</td></tr><tr><td>pathway</td><td>1</td></tr><tr><td>spatial</td><td>1</td></tr><tr><td>spatial transcriptomics</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (11æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254009">GSE254009 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [TT-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253121">GSE253121 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253120">GSE253120 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [POINT-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298740">GSE298740 ç”Ÿç‰©åˆ¶å‰‚æ²»ç–—çš„ T2 é«˜å±é‡ç—‡å“®å–˜æ‚£è€…çš„è½¬å½•ç»„å­¦ï¼šæŠ— IgEã€æŠ— IL-5 å’ŒæŠ— IL-5R é¶å‘æ²»ç–—çš„æ¯”è¾ƒã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294022">GSE294022 äººç±»å­å®«æµ†æ¶²æ€§ç™Œç»†èƒå’Œè‚¿ç˜¤å¯¹ CTX-439 çš„ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313231">GSE313231 RNA-seq æ•°æ®æ¥è‡ªæ¥å— S-100 è¯±å¯¼çš„è‡ªèº«å…ç–«æ€§è‚ç‚ (AIH) æ¨¡å‹å¤„ç†çš„ Alb-WT Bicd2fl/fl å’Œ Alb-Cre Bicd2fl/fl å°é¼ çš„è‚ç»„ç»‡ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308896">GSE308896 ç™Œç»†èƒé€šè¿‡èƒ¶åŸè›‹ç™½ä¸ä¸­åŒ…å«çš„microRNAè½¬ç§»ä¾µè¢­æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294315">GSE294315 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ï¼ˆå°é¼ ï¼‰ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255668">GSE255668 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255667">GSE255667 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[FLAM-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255603">GSE255603 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[RIP-Seq]</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-14 21:35</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week502025/ rel=tag>Week502025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-12-14/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-14</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-16/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-16</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-25/>ç§‘ç ”æ—¥æŠ¥ 2026-01-25</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-24/>ç§‘ç ”æ—¥æŠ¥ 2026-01-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-23/>ç§‘ç ”æ—¥æŠ¥ 2026-01-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-22/>ç§‘ç ”æ—¥æŠ¥ 2026-01-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-21/>ç§‘ç ”æ—¥æŠ¥ 2026-01-21</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (88)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (88)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>